CONFERENCE SPONSORS


Gold Sponsor

Novo Nordisk



Visit website
| Request a rep contact

At Novo Nordisk, our purpose is to drive change to defeat diabetes and other serious chronic diseases such as obesity and rare blood and endocrine disorders.

Novo Nordisk is a leading global healthcare company, founded in 1923 and our heritage has given us experience and capabilities that enable us to expand access to our medicines and work to prevent and ultimately cure disease by pioneering scientific breakthroughs.

Headquartered in Denmark, Novo Nordisk employs approximately 42,700 people in 80 countries and markets its products in around 170 countries. Every day, millions of people all over the world rely on our products.

For more information visit novonordisk.co.uk

Silver Sponsor

Abbott’s Diabetes Care Division



Visit website

Abbott’s diabetes care division is a global leader in glucose monitoring systems. We are dedicated to helping people manage their diabetes and achieve their best health outcomes with innovative technology, such as the FreeStyle Libre system, allowing patients to monitor their glucose with a quick and easy scan.

For more information, such as how the FreeStyle Libre system and our digital health tools support healthcare professionals and their patients visit  www.freestylediabetes.co.uk

Other Sponsor
Mylan



Visit Website

Mylan is a global pharmaceutical company committed to setting new standards in healthcare. Working together around the world to provide 7 billion people access to high quality medicine, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We offer a growing portfolio of more than 7,500 marketed products around the world, including antiretroviral therapies on which more than 40% of people being treated for HIV/AIDS globally depend. We market our products in more than 165 countries and territories. We are one of the world's largest producers of active pharmaceutical ingredients. Every member of our more than 35,000-strong workforce is dedicated to creating better health for a better world, one person at a time.

In the UK, where some of medicines have been helping patients for more than 50 years, we have a portfolio of over 500 products that include branded, generic, over the counter, antiretroviral and biosimilar medicines. Learn more at www.mylan.co.uk.

 

Napp Pharmaceuticals Limited


Visit website

Napp Pharmaceuticals Limited is a UK healthcare company with a strong track record in bringing high-quality, innovative medicines to UK health professionals and their patients. We strive to offer new medicines and initiatives that support the NHS in delivering effective, high-quality, sustainable healthcare for the benefit of patients

Click here to receive updates from Napp regarding our products

 

AstraZeneca

Visit website

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal & Metabolism and Respiratory. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

AstraZeneca operates in five different locations in the UK, where around 8,300 employees work in research and development, manufacturing, supply, sales and marketing. We supply 40 different medicines to the NHS. The UK is also an important location for AstraZeneca’s clinical trials; in 2018, there were 201 trials at 376 centres in the UK, involving over 7,000 patients. For more information, please visit www.astrazeneca.co.uk

 

BOEHRINGER INGELHEIM IN THE UK

Visit Website

We are Boehringer Ingelheim - a different kind of pharmaceutical company. Family-owned. Purpose-led. Innovation-driven: We serve mankind by improving health for people and animals.

Making new and better medicines for humans and animals is at the heart of what we do. Our mission is to create breakthrough therapies that change lives. Established in 1885, we have always been independent and family-owned, meaning we have the freedom to pursue our purpose - identifying health challenges of the future, and targeting areas of need where we can do the most good.

By working collaboratively, we accelerate the delivery of medical breakthroughs to transform the lives of patients now, and for generations to come.

In the UK we do this through scientific innovation – taking on the biggest challenges in medicine. We invest in sustainable healthcare - planning for the long term alongside the NHS and our partners in the veterinary world. We support digital transformation by partnering with innovators to drive healthcare improvements.

We are committed to tackling the challenge of climate change and are a certified carbon neutral organisation. We serve local and global communities through our social impact programme and we support social entrepreneurs who find healthcare solutions for the most vulnerable.

More information can be found at www.boehringer-ingelheim.co.uk


This conference has been instigated and organised by South Asian Health Foundation. The sponsoring companies have had no input into the conference agenda, speaker selection or presentations.